Vitespen Completed Phase 2 Trials for Non-Small Cell Lung Carcinoma (NSCLC) / Lung Cancers / Pulmonary Cancer

IndicationsStatusPurposePhase
CompletedNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT00098085Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer